Wikileaks Creator, In Geneva, Denounces US Abuse Of Human Rights 04/11/2010 by Catherine Saez, Intellectual Property Watch 3 Comments In a police-secured, airless room full of Geneva journalists, Julian Assange, creator and director of Wikileaks, today gave details of what he described as United States abuse of human rights in the Afghanistan and Iraq wars, as well as an alleged muzzling of US press on those subjects. The United States will undergo its first Universal Periodic Review of the Human Rights Council tomorrow.
Big Pharma Stranglehold: Thwarting India As Independent Maker Of Blockbuster HIV Drugs? 28/10/2010 by Intellectual Property Watch 2 Comments Daniele Dionisio writes: The current break-through of multinational drug corporations in India couples with the protectionist policies pursued by the US and EU and with India’s obligations as a WTO member. Taken together, these realities mean a heavy threat to India’s freedom as independent provider of lifesaving, affordable and state-of-the-art antiretroviral medicines to the resource-limited countries.
European Ruling Could Reshape Collective Copyright Levy System 25/10/2010 by Dugie Standeford for Intellectual Property Watch Leave a Comment In a ruling expected to rock Europe’s controversial copyright levy system, the European Court of Justice held on 20 October that governments may impose fees on digital reproduction equipment to compensate rights holders only when the devices are likely to be used for private copying.
Flexibility In Government Procurement Needed For Developing Countries 22/10/2010 by Intellectual Property Watch 3 Comments If public procurement for innovation is to be seen as part of developing countries’ industrial-policy portfolio, a recent paper argues accession to the GPA would not help, and advises against it, writes Riaz K. Tayob.
Emerging Economies’ New Initiative On Falsified And Substandard Medicines 22/10/2010 by William New and Kaitlin Mara for Intellectual Property Watch 2 Comments Several major generic-medicine producing nations last week held a discussion on the dangers of compromised medical products and joined together to urge new steps such as defining terms, focussing on public health and strengthening national regulatory capabilities beyond strictly enforcement actions that they say have been manipulated and at times counterproductive.
Minister: India Anticipates European Fix To Law Delaying Generics Shipments 20/10/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment Europe has promised at the “highest levels” to fix laws that caused generic medicine seizures in the Netherlands, the Indian Minister of Commerce and Industry said today. The minister is in Geneva for meetings on the ongoing Doha Round trade liberalisation talks at the World Trade Organization.
US Attorney General In China Talks Tough, Blurs Line, On IP 19/10/2010 by William New, Intellectual Property Watch Leave a Comment United States Attorney General Eric Holder today called on other governments to join in intensifying the fight against intellectual property infringement, on the theme that, “intellectual property crimes are not victimless.” But his law enforcement argument may need finessing to reach all stakeholders.
Special Report: Are Copyright Trolls The Future Of Digital Content Protection? 18/10/2010 by Dugie Standeford for Intellectual Property Watch 2 Comments Entrepreneurial law firms in the United States and United Kingdom are targeting suspected internet infringers through mass letter-writing and lawsuit campaigns. Are “copyright trolls” the way of the future for protecting digital content?
Sign Up For Email Alerts Of IP-Watch Briefs! 13/10/2010 by Intellectual Property Watch Leave a Comment Now available for Intellectual Property Watch readers: Email alerts for the IP-Watch Burble microblog, our breaking news briefs. A free service available to all, just sign up for email alerts here if you don’t already receive them. If you already receive IP-Watch email alerts, just scroll to the bottom of any email you receive (like this one) and click the link under “If you would like to modify the settings of your subscription,” which takes you to your individualised settings. Then add Burble to your categories. And of course you can also follow us on Twitter or by RSS feed, see www.ip-watch.org. If you have any questions, please contact us at info@ip-watch.ch.
An Eventful Week For IP Policymaking In The United States 02/10/2010 by William New, Intellectual Property Watch Leave a Comment The United States’ search for ways to spark its job growth has led to a focus on intellectual property rights, and this week several significant developments boiled over.